Press Releases for DDS

Press Releases
Dillard's, Inc. Reports Third Quarter Results
Dillard's, Inc. to Report Third Quarter Results
Business Wire Retail Report on October 2009 Retail Sales Figures
RidgewaterEquity.Com Free Fundamental Sector &Amp; Market Research on HAR, NLC, TEN, UMC, DDS and V
Business Wire Retail Report on September 2009 Retail Sales Figures
Business Wire Retail Report on August 2009 Retail Sales Figures
Labopharm's response for novel trazodone formulation accepted by FDA as complete - Designated as Class 2 resubmission
Dillard's, Inc. Reports Second Quarter Results
Labopharm comments on judgment in Purdue patent litigation
Labopharm submits response to FDA for novel antidepressant
Business Wire Retail Report on July 2009 Retail Sales Figures
Dillard’s, Inc. Reports July Sales Results
Labopharm files New Drug Submission with Health Canada for novel antidepressant
Labopharm to present at Canaccord Adams 29th Annual Global Growth Conference
IBM Smart Analytics System To Bring the Power of Analytics to Clients in Just Days ; Delivers Faster Time to Value at Lower Cost, While Requiring Less IT Expertise
Labopharm to host conference call Friday, August 7, 2009 at 8:30 a.m. (ET)
Investment Industry Regulatory Organization of Canada - Trade Resumption - Labopharm Inc. - DDS
Labopharm receives complete response letter from the U.S. FDA for novel antidepressant
Investment Industry Regulatory Organization of Canada - Trading Halt - Labopharm Inc. - DDS
BenchmarkJournal.Com Free Analyst Review for PNC, TEX, CNQ, DDS, AEE and PNR
Dillard’s, Inc. Says CIT Not a Participant in Revolving Credit Facility
Business Wire Retail Report on June 2009 Retail Sales Figures
Dillard’s, Inc. Reports June Sales Results
Labopharm amends debt facility agreement with Hercules
Dillard’s, Inc. Reports May Sales Results
Results of phase III study on Labopharm's novel antidepressant published in Psychiatry (Edgemont) Journal
Dillard’s, Inc. Declares Cash Dividend
Dillard's, Inc. Holds Annual Meeting of Shareholders
Dillard's, Inc. Reports First Quarter Results
Dillard's, Inc. To Report First Quarter Results - May 14 2009 6:30PM
Dillard’s, Inc. to Report First Quarter Results
Dillard’s, Inc. Reports April Sales Results
Labopharm announces details for first quarter results conference call and annual meeting
Beacon Equity Issues Trade Alerts on Retail Stocks in the News: ROST, JCP, AEO, TJX, GPS, DDS
Dillard’s, Inc. Reports March Sales Results
Labopharm reports results for Phase III study on twice-daily tramadol-acetaminophen formulation
Dillard’s, Inc. Declares Cash Dividend - Mar 10 2009 8:54AM
Labopharm to present at Cowen 29th Annual Health Care Conference
Dillard's, Inc. Reports Fourth Quarter and Fiscal Year Results
Dillard’s, Inc. Reports Fourth Quarter and Fiscal Year Results
Dillard’s, Inc. Reports February Sales Results
Labopharm Reports Results for Year End and Fourth Quarter Fiscal 2008
Labopharm to host conference call Thursday, February 26, 2009 at 8:30 a.m. (ET)
Labopharm to host conference call Thursday, February 26, 2009 at 8:30 a.m. (ET)
Dillard's, Inc. Reports January Sales Results - Feb 5 2009 10:02AM
Dillard’s, Inc. Reports January Sales Results
Dillard’s Celebrates Long Standing Partnership with Ronald McDonald House Charities®
Business Wire Retail Report On December 2008 Retail Sales Figures - Jan 8 2009 12:17PM
Dillard's, Inc. Reports December Sales Results
Dillard’s, Inc. Reports December Sales Results
Dillard’s, Inc. Names Lloyd Garrison as CDI Contractors, LLC Chief Executive Officer
Labopharm to host conference call to discuss FDA approval of once-daily RYZOLT(TM) on Tuesday, January 6, 2009 at 8:30 a.m. (ET)
Labopharm to host conference call to discuss FDA approval of once-daily RYZOLT(TM) on Tuesday, January 6, 2009 at 8:30 a.m. (ET)
Labopharm Announces FDA Approval of Once-Daily RYZOLT(TM) (Tramadol HCL Extended Release Tablets) for Management of Moderate to Moderately Severe Chronic Pain
Labopharm Announces FDA Approval of Once-Daily RYZOLT(TM) (Tramadol HCL Extended Release Tablets) for Management of Moderate to Moderately Severe Chronic Pain
Labopharm to host webcast presentation on novel trazodone formulation - tomorrow (Dec.16/08) at 10:00 a.m. ET
Labopharm to host webcast presentation on novel trazodone formulation - tomorrow (Dec.16/08) at 10:00 a.m. ET
Labopharm Comments on Recent Trading Activity - PR Newswire
Labopharm Comments on Recent Trading Activity - CNW
Dillard’s, Inc. Reports November Sales Results
Dillard’s, Inc. Declares Cash Dividend - Dec 3 2008 8:19AM
Zacks Analyst Blog Highlights: Phase Forward, Inc., Pepsi Bottling Group Inc., AT&T Inc., Dillard's Inc. And Einstein Noah Restaurant Group Inc.
Dillard's, Inc. Reports Third Quarter Results - Dec 1 2008 12:58PM
Dillard's, Inc. Reports Third Quarter Results - Nov 26 2008 7:57AM
Dillard’s, Inc. Reports Third Quarter Results
Labopharm to host webcast presentation on novel trazodone formulation for treatment of major depressive disorder - PR Newswire
Labopharm to host webcast presentation on novel trazodone formulation for treatment of major depressive disorder - CNW
Labopharm's NDA for Novel Trazodone Formulation accepted for review by FDA - PR Newswire
Labopharm's NDA for Novel Trazodone Formulation accepted for review by FDA - CNW
Dillard's, Inc. Announces Staff Reduction
Fitch U.S. Retail Outlook: Navigating a Difficult Path for Holiday and 2009
Fitch U.S. Retail Outlook: Navigating a Difficult Path for Holiday And2009
Dillard's Offers Exclusive Southern Living Christmas Cookbook to Benefit Ronald McDonald House Charities(R)
Labopharm announces change to Board of Directors - PR Newswire
Labopharm Reports Results for Third Quarter Fiscal 2008
Labopharm Reports Results for Third Quarter Fiscal 2008
Labopharm announces change to Board of Directors - CNW
Dillard's, Inc. Reports October Sales Results - Nov 6 2008 8:20AM
Dillard's, Inc. Provides Recap of Key Financial Strengths
Labopharm to host conference call Friday, November 7, 2008 at 8:30 a.m. (ET) - PR Newswire
Labopharm to host conference call Friday, November 7, 2008 at 8:30 a.m. (ET) - CNW
Standard & Poor's Announces Changes to U.S. Indices - 16-10-08
Country Stars Montgomery Gentry to Appear at Dillard's October 17th
Dillard's, Inc. Reports September Sales Results - Oct 8 2008 8:10AM
Labopharm Submits New Drug Application to FDA for DDS-04A to Treat Major Depression
Labopharm Submits New Drug Application to FDA for DDS-04A to Treat Major Depression
Dillard's, Inc. Reports Effects of Hurricane Ike
Creditntell.Com Announces the Launch of Its Retailer Future Outlook Analysis
Macerich and Dillard's Unveil Future Shopping Center Development
Labopharm to present at CIBC World Markets 7th Annual Eastern Institutional Investor Conference - PR Newswire
Labopharm to present at CIBC World Markets 7th Annual Eastern Institutional Investor Conference - CNW
Dillard's, Inc. Reports August Sales Results - Sep 9 2008 5:04PM
Business Wire Retail Report On August 2008 Retail Sales Figures
Dillard's, Inc. Reports August Sales Results - Sep 4 2008 8:25AM
Dillard's, Inc. Declares Cash Dividend - Sep 2 2008 9:00AM
Dillard's, Inc. Announces Completion of Acquisition of CDI Contractors, LLC
Dillard's, Inc. Announces Travel Agency Closure
Country Stars Montgomery Gentry to Appear at Dillard's September 5th
CORRECTING and REPLACING Dillard's, Inc. Reports Second Quarter Results
Dillard's, Inc. Reports Second Quarter Results